# New Jersey Resources Corp: financial statements, quarterly

NJR · NYSE · CIK 356309 · [Utilities](/sectors/utilities.md) · fiscal year ends Sep 30

Pages: [Overview](/companies/njr.md) · [Financials](/companies/njr/financials.md) · [Filings](/companies/njr/filings.md) · [Insiders](/companies/njr/insiders.md)

Standardized line items from XBRL company facts. Each value links to its filing; d marks a value derived from year-to-date figures. Other view: [annual](/companies/njr/financials.md?period=annual).

## Income statement

| Line item | Unit | Q4 FY2023 (2023-09-30) | Q1 FY2024 (2023-12-31) | Q2 FY2024 (2024-03-31) | Q3 FY2024 (2024-06-30) | Q4 FY2024 (2024-09-30) | Q1 FY2025 (2024-12-31) | Q2 FY2025 (2025-03-31) | Q3 FY2025 (2025-06-30) | Q4 FY2025 (2025-09-30) | Q1 FY2026 (2025-12-31) | Q2 FY2026 (2026-03-31) | Q3 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Revenue | $m | [163 d](/filings/0000356309-25-000093.md) | [321](/filings/0000356309-25-000024.md) | [433](/filings/0000356309-25-000031.md) | [210](/filings/0000356309-25-000046.md) | [266 d](/filings/0000356309-25-000093.md) | [359](/filings/0000356309-26-000021.md) | [569](/filings/0000356309-26-000029.md) | [235](/filings/0000356309-26-000037.md) | [188 d](/filings/0000356309-25-000093.md) | [441](/filings/0000356309-26-000021.md) | [641](/filings/0000356309-26-000029.md) | [258](/filings/0000356309-26-000037.md) |
| Cost of revenue | $m | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Operating income | $m | [64.3 d](/filings/0000356309-25-000093.md) | [136](/filings/0000356309-25-000024.md) | [170](/filings/0000356309-25-000031.md) | [5.9](/filings/0000356309-25-000046.md) | [146 d](/filings/0000356309-25-000093.md) | [190](/filings/0000356309-26-000021.md) | [280](/filings/0000356309-26-000029.md) | [(1.1)](/filings/0000356309-26-000037.md) | [40.4 d](/filings/0000356309-25-000093.md) | [179](/filings/0000356309-26-000021.md) | [301](/filings/0000356309-26-000029.md) | [31.9](/filings/0000356309-26-000037.md) |
| Interest expense | $m | [33.1 d](/filings/0000356309-23-000083.md) | [31.5](/filings/0000356309-24-000027.md) | [31.6](/filings/0000356309-24-000032.md) | [31.2](/filings/0000356309-25-000046.md) | [36.0 d](/filings/0000356309-25-000093.md) | [33.9](/filings/0000356309-26-000021.md) | [32.5](/filings/0000356309-26-000029.md) | [31.7](/filings/0000356309-26-000037.md) | [30.5 d](/filings/0000356309-25-000093.md) | [35.7](/filings/0000356309-26-000021.md) | [35.0](/filings/0000356309-26-000029.md) | [35.2](/filings/0000356309-26-000037.md) |
| Income tax | $m | [6.2 d](/filings/0000356309-25-000093.md) | [22.9](/filings/0000356309-25-000024.md) | [33.9](/filings/0000356309-25-000031.md) | [(2.8)](/filings/0000356309-25-000046.md) | [30.8 d](/filings/0000356309-25-000093.md) | [37.4](/filings/0000356309-26-000021.md) | [61.6](/filings/0000356309-26-000029.md) | [(5.1)](/filings/0000356309-26-000037.md) | [3.1 d](/filings/0000356309-25-000093.md) | [34.2](/filings/0000356309-26-000021.md) | [66.2](/filings/0000356309-26-000029.md) | [3.4](/filings/0000356309-26-000037.md) |
| Net income | $m | [37.0 d](/filings/0000356309-25-000093.md) | [89.4](/filings/0000356309-25-000046.md) | [121](/filings/0000356309-25-000046.md) | [(11.6)](/filings/0000356309-25-000046.md) | [91.1 d](/filings/0000356309-25-000093.md) | [131](/filings/0000356309-26-000037.md) | [204](/filings/0000356309-26-000037.md) | [(15.1)](/filings/0000356309-26-000037.md) | [15.1 d](/filings/0000356309-25-000093.md) | [122](/filings/0000356309-26-000037.md) | [219](/filings/0000356309-26-000037.md) | [9.7](/filings/0000356309-26-000037.md) |
| Diluted EPS | $ per share | not reported | [0.91](/filings/0000356309-25-000024.md) | [1.22](/filings/0000356309-25-000031.md) | [(0.12)](/filings/0000356309-25-000046.md) | not reported | [1.31](/filings/0000356309-26-000021.md) | [2.02](/filings/0000356309-26-000029.md) | [(0.15)](/filings/0000356309-26-000037.md) | not reported | [1.21](/filings/0000356309-26-000021.md) | [2.16](/filings/0000356309-26-000029.md) | [0.10](/filings/0000356309-26-000037.md) |
| Basic EPS | $ per share | not reported | [0.91](/filings/0000356309-25-000024.md) | [1.23](/filings/0000356309-25-000031.md) | [(0.12)](/filings/0000356309-25-000046.md) | not reported | [1.32](/filings/0000356309-26-000021.md) | [2.04](/filings/0000356309-26-000029.md) | [(0.15)](/filings/0000356309-26-000037.md) | not reported | [1.22](/filings/0000356309-26-000021.md) | [2.17](/filings/0000356309-26-000029.md) | [0.10](/filings/0000356309-26-000037.md) |

- Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
- Cost of revenue: not reported
- Operating income: us-gaap:OperatingIncomeLoss
- Interest expense: us-gaap:InterestExpense, us-gaap:InterestExpenseNonoperating
- Income tax: us-gaap:IncomeTaxExpenseBenefit
- Net income: us-gaap:NetIncomeLoss
- Diluted EPS: us-gaap:EarningsPerShareDiluted
- Basic EPS: us-gaap:EarningsPerShareBasic

## Balance sheet

| Line item | Unit | FY2023 (2023-09-30) | Q1 FY2024 (2023-12-31) | Q2 FY2024 (2024-03-31) | Q3 FY2024 (2024-06-30) | FY2024 (2024-09-30) | Q1 FY2025 (2024-12-31) | Q2 FY2025 (2025-03-31) | Q3 FY2025 (2025-06-30) | FY2025 (2025-09-30) | Q1 FY2026 (2025-12-31) | Q2 FY2026 (2026-03-31) | Q3 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Cash and equivalents | $m | [1.0](/filings/0000356309-25-000093.md) | [2.7](/filings/0000356309-25-000024.md) | [5.0](/filings/0000356309-25-000031.md) | [22.4](/filings/0000356309-25-000046.md) | [1.0](/filings/0000356309-25-000093.md) | [1.9](/filings/0000356309-26-000021.md) | [83.7](/filings/0000356309-26-000029.md) | [0.9](/filings/0000356309-26-000037.md) | [0.6](/filings/0000356309-26-000037.md) | [2.4](/filings/0000356309-26-000021.md) | [125](/filings/0000356309-26-000029.md) | [34.0](/filings/0000356309-26-000037.md) |
| Current assets | $m | [532](/filings/0000356309-24-000083.md) | [677](/filings/0000356309-24-000027.md) | [554](/filings/0000356309-24-000032.md) | [534](/filings/0000356309-24-000043.md) | [555](/filings/0000356309-25-000093.md) | [731](/filings/0000356309-25-000024.md) | [679](/filings/0000356309-25-000031.md) | [562](/filings/0000356309-25-000046.md) | [570](/filings/0000356309-26-000037.md) | [781](/filings/0000356309-26-000021.md) | [730](/filings/0000356309-26-000029.md) | [619](/filings/0000356309-26-000037.md) |
| Total assets | $m | [6,537](/filings/0000356309-24-000083.md) | [6,749](/filings/0000356309-24-000027.md) | [6,647](/filings/0000356309-24-000032.md) | [6,784](/filings/0000356309-24-000043.md) | [6,982](/filings/0000356309-25-000093.md) | [7,194](/filings/0000356309-25-000024.md) | [7,266](/filings/0000356309-25-000031.md) | [7,274](/filings/0000356309-25-000046.md) | [7,579](/filings/0000356309-26-000037.md) | [7,906](/filings/0000356309-26-000021.md) | [7,943](/filings/0000356309-26-000029.md) | [8,024](/filings/0000356309-26-000037.md) |
| Current liabilities | $m | [807](/filings/0000356309-24-000083.md) | [962](/filings/0000356309-24-000027.md) | [789](/filings/0000356309-24-000032.md) | [894](/filings/0000356309-24-000043.md) | [888](/filings/0000356309-25-000093.md) | [819](/filings/0000356309-25-000024.md) | [732](/filings/0000356309-25-000031.md) | [739](/filings/0000356309-25-000046.md) | [781](/filings/0000356309-26-000037.md) | [938](/filings/0000356309-26-000021.md) | [777](/filings/0000356309-26-000029.md) | [937](/filings/0000356309-26-000037.md) |
| Long-term debt | $m | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Current portion of debt | $m | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Short-term borrowings | $m | [252](/filings/0000356309-24-000083.md) | [269](/filings/0000356309-24-000027.md) | [196](/filings/0000356309-24-000032.md) | [255](/filings/0000356309-24-000043.md) | [292](/filings/0000356309-25-000093.md) | [337](/filings/0000356309-25-000024.md) | [162](/filings/0000356309-25-000031.md) | [307](/filings/0000356309-25-000046.md) | [196](/filings/0000356309-26-000037.md) | [369](/filings/0000356309-26-000021.md) | [150](/filings/0000356309-26-000029.md) | [220](/filings/0000356309-26-000037.md) |
| Shareholders' equity | $m | [1,991](/filings/0000356309-25-000093.md) | [2,066](/filings/0000356309-25-000046.md) | [2,179](/filings/0000356309-25-000046.md) | [2,143](/filings/0000356309-25-000046.md) | [2,200](/filings/0000356309-26-000037.md) | [2,313](/filings/0000356309-26-000037.md) | [2,478](/filings/0000356309-26-000037.md) | [2,424](/filings/0000356309-26-000037.md) | [2,392](/filings/0000356309-26-000037.md) | [2,472](/filings/0000356309-26-000037.md) | [2,649](/filings/0000356309-26-000037.md) | [2,643](/filings/0000356309-26-000037.md) |

- Cash and equivalents: us-gaap:CashAndCashEquivalentsAtCarryingValue
- Current assets: us-gaap:AssetsCurrent
- Total assets: us-gaap:Assets
- Current liabilities: us-gaap:LiabilitiesCurrent
- Long-term debt: not reported
- Current portion of debt: not reported
- Short-term borrowings: us-gaap:ShortTermBorrowings
- Shareholders' equity: us-gaap:StockholdersEquity

## Cash flow

| Line item | Unit | Q4 FY2023 (2023-09-30) | Q1 FY2024 (2023-12-31) | Q2 FY2024 (2024-03-31) | Q3 FY2024 (2024-06-30) | Q4 FY2024 (2024-09-30) | Q1 FY2025 (2024-12-31) | Q2 FY2025 (2025-03-31) | Q3 FY2025 (2025-06-30) | Q4 FY2025 (2025-09-30) | Q1 FY2026 (2025-12-31) | Q2 FY2026 (2026-03-31) | Q3 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Operating cash flow | $m | [91.1 d](/filings/0000356309-25-000093.md) | [46.4](/filings/0000356309-25-000024.md) | [292 d](/filings/0000356309-25-000031.md) | [24.3 d](/filings/0000356309-25-000046.md) | [64.5 d](/filings/0000356309-25-000093.md) | [(9.0)](/filings/0000356309-26-000021.md) | [423 d](/filings/0000356309-26-000029.md) | [(28.9) d](/filings/0000356309-26-000037.md) | [81.2 d](/filings/0000356309-25-000093.md) | [26.7](/filings/0000356309-26-000021.md) | [563 d](/filings/0000356309-26-000029.md) | [(11.6) d](/filings/0000356309-26-000037.md) |
| Capital expenditure | $m | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Dividends paid | $m | [38.0 d](/filings/0000356309-25-000093.md) | [41.0](/filings/0000356309-25-000024.md) | [41.2 d](/filings/0000356309-25-000031.md) | [41.3 d](/filings/0000356309-25-000046.md) | [41.6 d](/filings/0000356309-25-000093.md) | [44.8](/filings/0000356309-26-000021.md) | [45.0 d](/filings/0000356309-26-000029.md) | [45.1 d](/filings/0000356309-26-000037.md) | [45.2 d](/filings/0000356309-25-000093.md) | [47.7](/filings/0000356309-26-000021.md) | [47.9 d](/filings/0000356309-26-000029.md) | [47.9 d](/filings/0000356309-26-000037.md) |
| Share repurchases | $m | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |

- Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities
- Capital expenditure: not reported
- Dividends paid: us-gaap:PaymentsOfDividendsCommonStock
- Share repurchases: not reported

## Shares

| Line item | Unit | Q1 FY2023 (2022-12-31) | Q2 FY2023 (2023-03-31) | Q3 FY2023 (2023-06-30) | Q1 FY2024 (2023-12-31) | Q2 FY2024 (2024-03-31) | Q3 FY2024 (2024-06-30) | Q1 FY2025 (2024-12-31) | Q2 FY2025 (2025-03-31) | Q3 FY2025 (2025-06-30) | Q1 FY2026 (2025-12-31) | Q2 FY2026 (2026-03-31) | Q3 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Diluted shares (weighted) | millions of shares | [97.1](/filings/0000356309-24-000027.md) | [97.6](/filings/0000356309-24-000032.md) | [97.9](/filings/0000356309-24-000043.md) | [98.6](/filings/0000356309-25-000024.md) | [99.1](/filings/0000356309-25-000031.md) | [99.0](/filings/0000356309-25-000046.md) | [100](/filings/0000356309-26-000021.md) | [101](/filings/0000356309-26-000029.md) | [100](/filings/0000356309-26-000037.md) | [101](/filings/0000356309-26-000021.md) | [101](/filings/0000356309-26-000029.md) | [102](/filings/0000356309-26-000037.md) |

- Diluted shares (weighted): us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding

Shares outstanding: 101,467,946 at 2026-07-31, from the cover of the [10-Q filed 2026-08-04](/filings/0000356309-26-000037.md) (dei:EntityCommonStockSharesOutstanding).

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:22 ET. No prices; not investment advice.